Skip to main content

Table 3 Subgroup analysis of observation, laser photocoagulation, and anti-VEGF management of RAM

From: Observation, laser photocoagulation or anti-VEGF therapy in the management of retinal arterial macroaneurysms

 

Observatio (n = 124)

Laser Photocoagulatio (n = 80)

Anti-VEGF (n = 20)

O. vs L.a[n(O.) = 112, n(L.) = 80]

O. vs A.a[n(O.) = 22, n(L.) =  20]

L. vs A.a[n(L.) = 7,n(A.) = 9]

p

p

p

Interval (m)

26.21 ± 2.74

30.43 ± 3.35

9.43 ± 1.35

0.190

0.800

0.343

Exudative (%)

66(53.2)

48(60.0)

9(45)

0.116

0.863

0.001**

Initial LogMAR VA

(mean VA in decimal)

0.82 ± 0.75

(0.15)

0.79 ± 0.60

(0.16)

1.06 ± 0.63

(0.09)

0.132

0.949

0.010**

VA

-0.34 ± 0.68

-0.17 ± 0.58

-0.45 ± 0.62

0.918

0.733

0.049**

Initial CMT (μm)

383.87 ± 176.91

434.33 ± 118.59

526.35 ± 187.18

0.192

0.013**

0.088

CMT (μm)

-148.26 ± 138.99

-185.61 ± 130.37

-287.45 ± 171.87

0.261

0.005**

0.047**

  1. CMT Central macular thickness, VA Visual acuity, O Observation, L Laser photocoagulation, A Anti-VEGF treatment
  2. aHead-to-head comparison studies of subgroups
  3. **P < 0.05